Dr Faisal Khursheed Siddiqi, MD in Cherry Hill, NJ - Medicare Cardiac Electrophysiology

Dr Faisal Khursheed Siddiqi, MD is a medicare enrolled "Internal Medicine - Clinical Cardiac Electrophysiology" physician in Cherry Hill, New Jersey. He went to Rutgers School Of Dental Medicine and graduated in 2005 and has 19 years of diverse experience with area of expertise as Cardiac Electrophysiology. He is a member of the group practice One Oak Medical Group Llc and his current practice location is 1 Brace Rd, Suite C, Cherry Hill, New Jersey. You can reach out to his office (for appointments etc.) via phone at (856) 428-4100.

Dr Faisal Khursheed Siddiqi is licensed to practice in New Jersey (license number 25MA09305300) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1861676678.

Contact Information

	Dr Faisal Khursheed Siddiqi, MD
	1 Brace Rd, Suite C, Cherry Hill, NJ 08034-2600
	(856) 428-4100
	(856) 428-5748

Physician's Profile

Full Name	Dr Faisal Khursheed Siddiqi
Gender	Male
Speciality	Cardiac Electrophysiology
Experience	19 Years
Location	1 Brace Rd, Cherry Hill, New Jersey
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Faisal Khursheed Siddiqi attended and graduated from Rutgers School Of Dental Medicine in 2005

NPI Data:

NPI Number: 1861676678
Provider Enumeration Date: 12/28/2007
Last Update Date: 02/03/2017

Medicare PECOS Information:

PECOS PAC ID: 7113160730
Enrollment ID: I20130830000023

Medical Identifiers

Medical identifiers for Dr Faisal Khursheed Siddiqi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861676678	NPI	-	NPPES
0359483	Medicaid	NJ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0000X	Internal Medicine - Cardiovascular Disease	25MA09305300 (New Jersey)	Secondary
207RC0001X	Internal Medicine - Clinical Cardiac Electrophysiology	25MA09305300 (New Jersey)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
One Oak Medical Group Llc	9931467941	16

News Archive

FDA nod for pediatric Berlin heart

The U.S. Food and Drug Administration (FDA) has approved the Berlin Heart for pediatric patients waiting for heart transplants. The ventricular assist device is similar to the one worn by former Vice President Dick Cheney but scaled down in size for children and babies.

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Exiqon A/S today announced results for the first nine months of 2010 ending 30 September 2010. In the third quarter of 2010, organic growth in life science research product sales was 45% when excluding OEM sales and reagent sales associated with license agreements. Operating expenses decreased 31% to DKK 19.9 million in the third quarter.

Study highlights need to focus on all opioid prescribers to curb epidemic

A cross-section of opioid prescribers that typically do not prescribe large volumes of opioids, including primary care physicians, surgeons and non-physician health care providers, frequently prescribe opioids to high-risk patients, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Faisal Khursheed Siddiqi allows following entities to bill medicare on his behalf.

Entity Name	One Oak Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1669997359 PECOS PAC ID: 9931467941 Enrollment ID: O20171221000605

News Archive

FDA nod for pediatric Berlin heart

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Study highlights need to focus on all opioid prescribers to curb epidemic

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Faisal Khursheed Siddiqi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Faisal Khursheed Siddiqi, MD 1 Brace Rd, Suite C, Cherry Hill, NJ 08034-2600 Ph: (856) 428-4100	Dr Faisal Khursheed Siddiqi, MD 1 Brace Rd, Suite C, Cherry Hill, NJ 08034-2600 Ph: (856) 428-4100

News Archive

FDA nod for pediatric Berlin heart

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Study highlights need to focus on all opioid prescribers to curb epidemic

Internal Medicine Doctors in Cherry Hill, NJ

Shagufta Ahsan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942
Dr. Alexandr Zaslavsky, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023
Dr. Tolulope Adesiyun Agunbiade, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900
Garo Charles Avetian, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107
Matthew Everwine, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124
Dr. Behjath Jafry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823
William C Groh, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300

Dr Faisal Khursheed Siddiqi, MD - Medicare Cardiac Electrophysiology in Cherry Hill, NJ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

FDA nod for pediatric Berlin heart

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Study highlights need to focus on all opioid prescribers to curb epidemic

Medicare Reassignments

FDA nod for pediatric Berlin heart

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Study highlights need to focus on all opioid prescribers to curb epidemic

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA nod for pediatric Berlin heart

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

First study to evaluate treatment based on molecular profiling of advanced pancreatic cancer

Exiqon 2010 first nine months revenue increases 36% to DKK 65.7 million

Study highlights need to focus on all opioid prescribers to curb epidemic

Internal Medicine Doctors in Cherry Hill, NJ